For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Intellia Therapeutics Inc’s stock clocked out at $12.28, up 6.50% from its previous closing price of $11.53. In other words, the price has increased by $6.50 from its previous closing price. On the day, 5.91 million shares were traded.
Ratios:
To gain a deeper understanding of NTLA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.73 and its Current Ratio is at 6.73. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on January 27, 2025, Downgraded its rating to Equal-Weight and sets its target price to $11 from $56 previously.
On February 23, 2024, Goldman Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $136 to $32.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 29 ’25 when Bhanji Muna sold 265 shares for $9.97 per share. The transaction valued at 2,642 led to the insider holds 19,468 shares of the business.
Dube Michael P sold 1,372 shares of NTLA for $16,711 on Jan 03 ’25. The VP, Chief Accounting Officer now owns 45,640 shares after completing the transaction at $12.18 per share. On Jan 03 ’25, another insider, BASTA JAMES, who serves as the EVP, General Counsel of the company, sold 7,074 shares for $12.18 each. As a result, the insider received 86,161 and left with 74,497 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 29.03 while its Price-to-Book (P/B) ratio in mrq is 1.30.
Stock Price History:
Over the past 52 weeks, NTLA has reached a high of $34.87, while it has fallen to a 52-week low of $8.96. The 50-Day Moving Average of the stock is 7.83%, while the 200-Day Moving Average is calculated to be -35.00%.
Shares Statistics:
A total of 101.80M shares are outstanding, with a floating share count of 96.15M. Insiders hold about 5.60% of the company’s shares, while institutions hold 91.78% stake in the company.
